Exploration of Dalpiciclib Plus HDACi in HR+/HER2- Advanced Breast Cancer After Failure of CDK4/6 Inhibitor
Clinical trial NCT06556862 · NOT_YET_RECRUITING
Trial details
- NCT number
- NCT06556862
- Sponsor
- Beijing 302 Hospital
- Status
- NOT_YET_RECRUITING
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2025-10-01
- Primary completion
- 2026-12-31
- Enrollment
- 155
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.